A handful of companies are blazing a trail from reactionary to proactive medicine in a number of ways. From leveraging genome sequencing on an individual basis, to manipulating big data to mine emerging conditions across entire populations, these companies are leading the way to predict patient diagnosis intervention.

Genomics and the Future of Personalized Medicine

A handful of companies are blazing a trail from reactionary to proactive medicine in a number of ways. From leveraging genome sequencing on an individual basis, to manipulating big data to mine emerging conditions across entire populations, these companies are leading the way to predict patient diagnosis intervention.